IL105834A - Sulfur containing phosphonate compounds and pharmaceutical compositions containing them - Google Patents

Sulfur containing phosphonate compounds and pharmaceutical compositions containing them

Info

Publication number: IL105834A
Authority: IL; Israel
Prior art keywords: substituted; unsubstituted; alkyl; compound; hydrogen
Prior art date: 1992-05-29

Application number

IL10583493A

Other languages

English (en)

Other versions

IL105834A0 (en

Original Assignee

Procter & Gamble Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-29

Filing date

1993-05-28

Publication date

1999-10-28

1993-05-28 Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma

1993-09-22 Publication of IL105834A0 publication Critical patent/IL105834A0/xx

1999-10-28 Publication of IL105834A publication Critical patent/IL105834A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Removal Of Specific Substances (AREA)
Processing Of Solid Wastes (AREA)
Materials For Medical Uses (AREA)

IL10583493A 1992-05-29 1993-05-28 Sulfur containing phosphonate compounds and pharmaceutical compositions containing them IL105834A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US89130992A	1992-05-29	1992-05-29

Publications (2)

Publication Number	Publication Date
IL105834A0 IL105834A0 (en)	1993-09-22
IL105834A true IL105834A (en)	1999-10-28

Family

ID=25397954

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL10583493A IL105834A (en)	1992-05-29	1993-05-28	Sulfur containing phosphonate compounds and pharmaceutical compositions containing them
IL11964896A IL119648A0 (en)	1992-05-29	1996-11-19	Sulfur containing phosphonate compounds and pharmaceutical compositions containing them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL11964896A IL119648A0 (en)	1992-05-29	1996-11-19	Sulfur containing phosphonate compounds and pharmaceutical compositions containing them

Country Status (24)

Country	Link
US (1)	US5824661A (cs)
EP (1)	EP0642519B1 (cs)
JP (1)	JPH07507315A (cs)
KR (1)	KR950701929A (cs)
CN (2)	CN1061049C (cs)
AT (1)	ATE195317T1 (cs)
AU (1)	AU669372B2 (cs)
CA (2)	CA2188066C (cs)
CZ (1)	CZ296794A3 (cs)
DE (1)	DE69329199D1 (cs)
DK (1)	DK0642519T3 (cs)
FI (1)	FI945593A0 (cs)
HU (1)	HUT69699A (cs)
IL (2)	IL105834A (cs)
MX (1)	MX9303251A (cs)
MY (1)	MY109736A (cs)
NO (1)	NO305960B1 (cs)
NZ (1)	NZ253524A (cs)
PL (1)	PL175475B1 (cs)
RU (1)	RU2136691C1 (cs)
SG (1)	SG50518A1 (cs)
SK (1)	SK144494A3 (cs)
WO (1)	WO1993024496A1 (cs)
ZA (1)	ZA933759B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2118967T3 (es) *	1992-05-29	1998-10-01	Procter & Gamble Pharma	Compuestos de fosfonato que contienen nitrogeno cuaternario para tratar un metabolismo anormal del calcio y fosfato asi como el calculo y la placa dentales.
EP0642521A1 (en) *	1992-05-29	1995-03-15	Procter & Gamble Pharmaceuticals	Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
TW401276B (en) *	1993-10-07	2000-08-11	Zeneca Ltd	Novel compounds and a method of controlling growth of plants
US5728650A (en) *	1993-10-07	1998-03-17	Zeneca Limited	Herbicidal aza bisphosphonic acids and compositions containing the same
US5646134A (en) *	1994-04-21	1997-07-08	Merck & Co., Inc.	Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
CA2267984A1 (en) *	1996-10-09	1998-04-16	Elizanor Biopharmaceuticals, Inc.	Diphosphonate therapeutic compounds
US6121253A (en) *	1998-11-20	2000-09-19	Merck Frosst Canada & Co.	Prostaglandin conjugates for treating or preventing bone disease
PL196485B1 (pl) *	2000-05-11	2008-01-31	Inst Farmaceutyczny	Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
EP1591122B1 (en) *	2000-06-20	2012-09-26	Novartis AG	Method of administering bisphosphonates
FR2947266B1 (fr) *	2009-06-26	2011-06-17	Servier Lab	Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI730039B (zh) *	2016-01-29	2021-06-11	日商富士藥品股份有限公司	新穎雙膦酸化合物
US11793452B2 (en)	2019-10-03	2023-10-24	Johnson & Johnson Consumer Inc.	Method of visualizing and quantifying remineralization

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3957858A (en) *	1970-04-13	1976-05-18	Monsanto Company	Substituted ethane diphosphonic acids and salts and esters thereof
US4208401A (en) *	1977-08-19	1980-06-17	Colgate-Palmolive Company	Quaternary ammonium alkylene diphosphonate anti-calculus agents
DE2745083C2 (de) *	1977-10-07	1985-05-02	Henkel KGaA, 4000 Düsseldorf	Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
DE3016289A1 (de) *	1980-04-28	1981-10-29	Henkel KGaA, 4000 Düsseldorf	Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
FR2531088B1 (fr) *	1982-07-29	1987-08-28	Sanofi Sa	Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
AU566610B2 (en) *	1983-09-15	1987-10-22	University Of Bath	Disinfection of contact lenses
FR2558837B1 (fr) *	1984-01-26	1986-06-27	Sanofi Sa	Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
DE3428524A1 (de) *	1984-08-02	1986-02-13	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5104863A (en) *	1984-12-21	1992-04-14	The Procter & Gamble Company	Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism
US4687768A (en) *	1984-12-21	1987-08-18	The Procter & Gamble Company	Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
IL77243A (en) *	1984-12-21	1996-11-14	Procter & Gamble	Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4902679A (en) *	1985-12-13	1990-02-20	Norwich Eaton Pharmaceuticals, Inc.	Methods of treating diseases with certain geminal diphosphonates
ES2038692T4 (es) *	1986-11-21	2012-02-10	Novartis Ag	Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos.
DE3640938A1 (de) *	1986-11-29	1988-06-01	Boehringer Mannheim Gmbh	Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel
US4868164A (en) *	1986-12-19	1989-09-19	Norwich Eaton Pharmaceuticals, Inc.	Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5071840A (en) *	1986-12-19	1991-12-10	Norwich Eaton Pharmaceuticals, Inc.	Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
IL86951A (en) *	1987-07-06	1996-07-23	Procter & Gamble Pharma	Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
EP0320455B1 (de) *	1987-12-11	1993-06-09	Ciba-Geigy Ag	Araliphatylaminoalkandiphosphonsäuren
US4933472A (en) *	1988-04-08	1990-06-12	Yamanouchi Pharmaceutical Co., Ltd.	Substituted aminomethylenebis(phosphonic acid) derivatives
TW198039B (cs) *	1988-11-28	1993-01-11	Ciba Geigy Ag
WO1990012017A1 (en) *	1989-04-03	1990-10-18	The Upjohn Company	Geminal bisphosphonic acids and derivatives as anti-arthritic agents
DE4011777A1 (de) *	1989-04-14	1990-10-18	Ciba Geigy Ag	N-trisubstituierte aminoalkandiphosphonsaeuren
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
DE69023844T2 (de) *	1989-09-06	1996-06-20	Merck & Co Inc	Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren.
EP0510066A4 (en) *	1990-01-12	1992-12-02	Rhone-Poulenc Rorer International (Holdings) Inc.	1-azetidyl and 1-hexamethylenimine alkyl or aryl bisphosphonic acids and their use as pharmacological agents
ATE165603T1 (de) *	1991-09-05	1998-05-15	Toray Industries	Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel

1993
- 1993-05-26 HU HU9403408A patent/HUT69699A/hu unknown
- 1993-05-26 DE DE69329199T patent/DE69329199D1/de not_active Expired - Lifetime
- 1993-05-26 NZ NZ253524A patent/NZ253524A/en unknown
- 1993-05-26 SK SK1444-94A patent/SK144494A3/sk unknown
- 1993-05-26 CZ CZ942967A patent/CZ296794A3/cs unknown
- 1993-05-26 AU AU43917/93A patent/AU669372B2/en not_active Ceased
- 1993-05-26 DK DK93914151T patent/DK0642519T3/da active
- 1993-05-26 PL PL93306139A patent/PL175475B1/pl unknown
- 1993-05-26 SG SG1996003361A patent/SG50518A1/en unknown
- 1993-05-26 RU RU94046117A patent/RU2136691C1/ru active
- 1993-05-26 EP EP93914151A patent/EP0642519B1/en not_active Expired - Lifetime
- 1993-05-26 AT AT93914151T patent/ATE195317T1/de not_active IP Right Cessation
- 1993-05-26 KR KR1019940704307A patent/KR950701929A/ko not_active Abandoned
- 1993-05-26 WO PCT/US1993/004977 patent/WO1993024496A1/en not_active Ceased
- 1993-05-26 CA CA002188066A patent/CA2188066C/en not_active Expired - Fee Related
- 1993-05-26 CA CA002136818A patent/CA2136818C/en not_active Expired - Fee Related
- 1993-05-26 JP JP6500722A patent/JPH07507315A/ja active Pending
- 1993-05-28 IL IL10583493A patent/IL105834A/en not_active IP Right Cessation
- 1993-05-28 ZA ZA933759A patent/ZA933759B/xx unknown
- 1993-05-28 MY MYPI93001056A patent/MY109736A/en unknown
- 1993-05-29 CN CN93108419A patent/CN1061049C/zh not_active Expired - Fee Related
- 1993-05-31 MX MX9303251A patent/MX9303251A/es not_active IP Right Cessation
1994
- 1994-09-07 US US08/301,514 patent/US5824661A/en not_active Expired - Fee Related
- 1994-11-24 NO NO944499A patent/NO305960B1/no not_active IP Right Cessation
- 1994-11-28 FI FI945593A patent/FI945593A0/fi unknown
1996
- 1996-11-19 IL IL11964896A patent/IL119648A0/xx unknown
1999
- 1999-12-23 CN CN99127416A patent/CN1288008A/zh active Pending

Also Published As

Publication number	Publication date
PL175475B1 (pl)	1999-01-29
JPH07507315A (ja)	1995-08-10
MY109736A (en)	1997-05-31
NO944499D0 (no)	1994-11-24
EP0642519B1 (en)	2000-08-09
HU9403408D0 (en)	1995-02-28
NO305960B1 (no)	1999-08-23
SG50518A1 (en)	1998-07-20
ATE195317T1 (de)	2000-08-15
MX9303251A (es)	1994-05-31
CA2136818C (en)	2000-01-18
IL105834A0 (en)	1993-09-22
CA2188066A1 (en)	1993-11-30
RU2136691C1 (ru)	1999-09-10
CZ296794A3 (en)	1995-04-12
DK0642519T3 (da)	2000-09-18
DE69329199D1 (de)	2000-09-14
FI945593A7 (fi)	1994-11-28
KR950701929A (ko)	1995-05-17
CN1288008A (zh)	2001-03-21
EP0642519A1 (en)	1995-03-15
CA2188066C (en)	2000-12-05
AU4391793A (en)	1993-12-30
RU94046117A (ru)	1996-09-27
WO1993024496A1 (en)	1993-12-09
IL119648A0 (en)	1997-02-18
NO944499L (no)	1995-01-30
ZA933759B (en)	1994-01-20
US5824661A (en)	1998-10-20
CN1061049C (zh)	2001-01-24
NZ253524A (en)	1997-01-29
HK1014002A1 (en)	1999-09-17
FI945593A0 (fi)	1994-11-28
AU669372B2 (en)	1996-06-06
CN1096787A (zh)	1994-12-28
HUT69699A (en)	1995-09-28
CA2136818A1 (en)	1993-12-09
SK144494A3 (en)	1995-05-10

Legal Events

Date	Code	Title
2000-02-29	FF	Patent granted
2000-08-31	KB	Patent renewed
2004-02-08	RH1	Patent not in force

Publication	Publication Date	Title
EP0788362B1 (en)	2001-07-25	Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism
US5856314A (en)	1999-01-05	Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
EP0642519B1 (en)	2000-08-09	Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
EP0642518B1 (en)	1998-08-05	Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
CA2136822C (en)	2000-12-05	Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
CA2136821C (en)	1999-06-15	Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5753634A (en)	1998-05-19	Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
US5760021A (en)	1998-06-02	Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
HK1014002B (en)	2001-05-11	Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
HK1014000B (en)	2000-09-08	Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
IL105838A (en)	1998-03-10	Pharmaceutical compositions containing phosphonocarboxylates and some novel compounds of this type